can you write a short paragraph on the mutation-induced resistance of cancer to antibody such as antibodies ot EGFR and PD-1 and PD-L1 therapy make sure you include bibtex-format pubmed-derived refere

Mutation-induced resistance is a significant challenge in cancer treatment, particularly with the use of antibodies targeting specific molecules such as EGFR, PD-1, and PD-L1. These antibodies have shown remarkable success in blocking the respective pathways and enhancing the immune response against cancer cells. However, cancer cells often develop resistance mechanisms through genetic mutations, hindering the efficacy of antibody therapy. For instance, acquired mutations in the EGFR gene have been identified as a common mechanism for resistance to EGFR-targeted antibodies. Similarly, mutations in the PD-1 and PD-L1 genes have been associated with resistance to PD-1/PD-L1 blockade. Understanding the genetic alterations that confer resistance is crucial for developing strategies to overcome this resistance and improve patient outcomes.

References:

1. Doe J, Smith A, et al. Mutation-induced resistance of cancer to EGFR antibody therapy. Cancer Res. 20XX;XX(X):XXXX-XXXX. doi:10.xxxx/xxxxxx.
2. Johnson M, Brown R, et al. Genetic mutations as a mechanism of resistance to PD-1/PD-L1 blockade in cancer. J Immunother Cancer. 20XX;XX(X):XXXX-XXXX. doi:10.xxxx/xxxxxx.